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ABSTRACT 
 
Expression of Candidate Genes for Horn Growth in Early Bovine Development. 
(December 2009) 
Sarah M. Vitanza, B.S., Texas A&M University 
Co-Chairs of Advisory Committee: Dr. Clare A. Gill 
Dr. Penny K. Riggs
 
 
Bovine horns develop primarily after birth and the presence or absence of horns 
is due to a single gene.  It has been reported that the horn bud appears in the bovine 
embryo at d 60 of gestation.  Our hypothesis is that the gene that determines the presence 
of horns is expressed in osteoprogenitor cells of the early fetus and will affect the 
expression of RUNX2, MSX1, MSX2, and/or TWIST1. 
To test this hypothesis, bovine fetal samples were collected from commercial 
females at the Caviness Packing Company in Hereford, Texas.  Fetuses ranged from d 
28 to d 80 of gestation.  A survey of the expression of genes from the region on bovine 
chromosome 1 known to contain the locus that causes horns (IFNAR1 to SOD1), was 
conducted using qualitative and quantitative RT-PCR, and in situ hybridization.  Genes 
with known roles in osteogenesis and chrondrogenesis (MSX1, TWIST1, RUNX2 and 
SOX9) were included as positive controls. 
With the exception of OLIG1, which was only expressed in the brain, all of the 
genes investigated were expressed in fetal frontal and parietal bones by qualitative RT-
 
 
 
iv 
PCR.  The level of expression of C21orf59, C21orf66, IL10RB, and SFRS15 increased in 
the frontal bone of horned samples from d 55 to d 70 of gestation. 
At d 60 of gestation, a change in the shape of the frontal bone was observed, 
which has been reported to be the developmental stage when the horn bud appears.  At 
this time point, MSX1, TWIST1, RUNX2 and SOX9 were detected in frontal bone, in cells 
from the osteoblast lineage, as expected.  Furthermore, C21orf59, C21orf62, C21or66 
and SFRS15 from the polled interval were localized to developing mesenchyme, 
osteoblasts and/or osteoclasts of the frontal bone, suggesting that each of these genes has 
a role in intramembranous bone formation.  In addition, gradients of expressed C21orf66 
and SFRS15 were detected in developing endochondral bone.  There was evidence of an 
antisense transcript of C21orf66 expressed in the same cell types as the sense transcript.  
Further characterization of this antisense transcript demonstrated that it covered the 
entire sense transcript.  Based on observed expression in the mesenchyme, rather than 
just in mature osteoblasts or osteoclasts, C21orf66 and/or its antisense transcript become 
the most likely candidates for the polled locus. 
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1. INTRODUCTION 
 Horns cost cattle producers and the meat industry more than an estimated $22 
million every year from bruised carcasses and damaged hides.  The presence or absence 
of horns in Bos taurus cattle is controlled by an autosomal locus with 2 alleles and the 
polled phenotype is due to a dominant mutation (Georges et al., 1993).  Producers are 
unable to readily distinguish heterozygous polled animals from homozygous polled 
animals, thus eradication of horns from a herd can be a time-consuming process.  The 
region known to contain the polled locus is located on bovine chromosome (BTA) 1q12 
in the interval from IFNAR1 to SOD1 (Figure 1.1; Appendix B), which corresponds to 
human chromosome (HSA) 21q21-22 and coincides with part of the Down syndrome 
critical region (Davis et al., 1999). 
 Horns develop on the frontal bone adjacent to the coronal suture between the 
frontal and the parietal bone.  Recent histological analysis of horn samples from neonatal 
and 5 to 6 mo old Bos indicus influenced cattle provides evidence that horns develop 
through intramembranous ossification, which is how the flat bones of the skull are 
formed (Wunderlich, 2008).  However, in neonatal samples, none of the genes from the 
polled critical interval were differentially expressed in skin and horn, suggesting that the 
polled locus most likely has its primary effect during fetal development (Wunderlich, 
2008).  The objective of this study is to conduct a survey of gene expression in bovine 
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Figure 1.1. Polled interval on bovine chromosome 1.  Gene names above the horizontal 
line are based on human nomenclature.  Bovine markers are listed below the line.  
Region spans from 1,278,530 to 2,920,913 of the Btau4.0 assembly of the bovine 
genome sequence.  Modified from Wunderlich (2008). 
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fetal samples at various stages of development for genes in the region on BTA1 
(IFNAR1 to SOD1) known to contain the locus that causes horns, along with other genes 
with known roles in the osteogenesis and chrondrogenesis pathways. 
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2. LITERATURE REVIEW 
2.1 Economic Importance 
Horns are problematic for cattle producers and the meat industry.  More than $22 
million is estimated to be lost every year from bruised carcasses and damaged hides due 
to horns.  Bruising was one of the top 10 concerns for beef producers identified in the 
2000 National Beef Quality Audit (McKenna et al., 2002). However, in the 2005 
National Beef Quality Audit (Smith et al., 2006), the number of horned cattle and 
carcasses damaged had not changed significantly. 
Producers dehorn cattle to alleviate potential damage to other cattle and to 
prevent harm to caretakers.  Dehorning has been one of the main practices used to 
remove horns but it can cause additional stress to the animal that negatively affects gain 
(Goonewardene and Hand, 1991), lead to a risk of infection at the wound site, and cause 
potential injury to caretakers during the dehorning procedure.  Producers have moved to 
using cattle that are polled in order to eliminate the need for dehorning (Goonewardene 
et al., 1999).  Distinguishing homozygous polled from heterozygous polled cattle is 
difficult for cattle breeders because of the recessive inheritance of the horned allele. 
Despite efforts to eradicate horns by removal of horned animals, heterozygous polled 
animals retain the recessive allele and can produce horned offspring.  Identification of 
genetic factors that affect horn growth and development could aid producers to select 
against horns. 
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2.2 Horns 
The presence or absence of horns in Bos taurus cattle is controlled by an 
autosomal locus with 2 alleles (Georges et al., 1993).  The horned phenotype is due to a 
homozygous recessive gene (pp) (Long and Gregory, 1978) and the polled phenotype is 
due to a dominant mutation (P). 
Additionally, there is a separate gene that causes scurs, which are horn-like 
growths above the frontal bone in the same location as a horn. The scur phenotype (Sc) 
appears to be expressed as a sex-influenced trait with incomplete penetrance.  Scurs can 
vary in size from small and scab-like to large and horn-like (Asai et al., 2004). This 
variation in size makes it difficult for producers and breed associations to correctly 
classify the polled, scurred and horned phenotypes.  Buchanan Smith (1927) proposed 
that there is a third locus affecting horn growth based on observations in crosses between 
Aberdeen-Angus bulls and Angoni (a zebu breed) and Mashukulumbwe (Mashona 
sanga-zebu) cows in Northern Rhodesia (now Zambia), as well as in the Wild White 
Park cattle that formed the Park Cattle breed.  This later became known as the African 
horn gene (Ha) and is thought to be epistatic to polled in males but not in females and 
inherited like scurs, in a sex-limited manner (White and Ibsen, 1936).  None of these 
genes have yet been identified. 
In 1829, Sandifort reported that the bony core of the horn is a compound 
structure composed of a frontal outgrowth or pedicle, a superimposed ossification in the 
cartilaginous matrix, and a frontal sinus that will extend up into the pedicle (cited by 
Gadow, 1902).  In contrast to this, others postulated that the horn is a result of a separate 
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center of ossification originating in tissues above the periosteum (dermal and 
subcutaneous connective tissues surrounding bone), which subsequently fuses to the 
frontal bone and appears as a simple bony growth (Dove, 1935).  Based on cases of 
regrowth following surgical removal of horns, Hoffsis (1995) suggested that the corium, 
the area of cells located at the junction of the horn and skin, is the primary site of horn 
growth. 
2.3 Cranial Development 
 Craniofacial morphogenesis is regulated by interactions between the surface and 
neural ectoderms, endoderm, paraxial mesoderm and cranial neural crest (Francis-West 
et al., 1998).  After migration of neural crest cells has occurred, the mesenchyme of the 
head develops from the paraxial mesoderm and the cranial neural crest (Noden, 1983).  
As cranial mesenchymal cells proliferate, causing expansion and increased extracellular 
space, the neural folds bulge outward to create the head region. 
Through a series of experiments, mostly done with a quail-chick chimera culture 
system, it was determined that the bones of the cranial vault, the overlying periosteum 
and the intervening sutures are derived from the dermal layer (Noden, 1983).  The 
cranial neural cells migrate to the facial region in response to ecto-mesenchymal 
interactions (Abzhanov et al., 2007).  These cells differentiate into skeletogenic 
progenitor cells, forming condensations, which then differentiate into osteoblasts.  The 
osteoblasts produce a bone-specific matrix as a scaffold for bone development (de 
Crombrugghe et al., 2001).  In the head, this leads to the development of the cranial 
bones, which include the frontal bone, parietal bones, temporal bones and occipital bone.  
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These 4 major bones make up the skullcap and are crucial in normal developing calvaria 
(skull).   
Jiang et al. (2002) utilized a transgenic mouse carrying a permanent neural crest 
lineage marker and DiI labeling of cranial mesoderm to demonstrate that the murine 
frontal bone is derived from the cranial neural crest, whereas the parietal bone is derived 
from mesoderm.  Horns develop on the frontal bone adjacent to the coronal suture with 
the parietal bone, so the finding that these 2 bones are derived from different cell 
lineages is relevant to the current study. 
2.4 Bone Development 
 Osteogenesis is the formation and development of bone, which occurs by 
replacing preexisting connective tissue (Kierszenbaum, 2002).  There are 2 processes 
through which bone can develop: 1) intramembranous ossification in which bone is 
directly made from the mesenchyme, and 2) endochondral ossification, in which there is 
a cartilage template that is replaced by bone. 
Bones of the skull and part of the clavicle are formed by intramembranous 
ossification, a multi-step process.  As the embryonic mesenchyme becomes more 
vascularized, these cells begin to develop into osteoprogenitor cells, pre-osteoblasts and 
then mature osteoblasts, which are cuboidal-type cells that produce the osteoid (bone) 
matrix (Kerr, 1999; Stein et al., 2004).  As the matrix becomes mineralized, the 
osteoblasts become osteocytes linked by canaliculi.  Trabeculae are formed from the 
linked osteocytes, as a radial structure in which hemopoietic tissues allow for blood 
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supply (Kerr, 1999).  As the bone develops it transforms from woven bone to lamellar 
bone. 
Endochondral ossification, a better understood process, gives rise to long bones 
that become the appendicular skeleton, facial bones, vertebrae, and lateral medial 
clavicles.  Like intramembranous ossification, the initial condensation of mesenchyme 
and the eventual formation of calcified bone are the same.  However, there is an 
intermediate step in which a cartilaginous template regulates growth and development of 
the bone (Ornitz and Marie, 2002).  Cartilage is needed to lengthen and increase the 
diameter of rapidly developing bones. 
Endochondral ossification occurs within the mesenchyme, as cells begin to 
proliferate into chondrocytes.  Proliferating chondrocytes begin to mature into 
hypertrophic chondrocytes forming the matrix.  As the matrix increases in size, the 
center becomes calcified.  This is the site of bone deposition.  The inner perichondral 
cells develop into osteoblasts and the center becomes a cylindrical collar.  As cartilage is 
removed, blood vessels traffic osteogenic cells to the site to allow for new bone deposits 
(Kerr, 1999). 
It has been described that horns develop via endochondral bone formation 
through a cartilage matrix; however, little histological data support this hypothesis 
(Fambach, 1901; Gadow, 1902).  After recent histological analysis of neonatal and 5 to 6 
month old Bos indicus influenced cattle, Wunderlich (2008) proposed that horns develop 
through intramembranous ossification.  Horns develop on the frontal bone adjacent to 
the coronal suture between the frontal bone and the parietal bone (Wunderlich, 2008).  
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The roles of these bones and the coronal suture in horn development remain unclear.  
The sutures between the flat bones of the skull function as the growth centers of the 
bones.  At the edges of these bones are osteogenic fronts that contain highly proliferating 
cells, which then differentiate (Connerney et al., 2008). 
Growth and development of the frontal and parietal bones are regulated by a 
number of osteogenic genes (Stein et al., 2004).  The principal osteogenic marker is runt-
related transcription factor 2 (RUNX2, previously known as CBFA1), which is initially 
observed when pluripotent mesenchymal stem cells are committed to the bone cell 
lineage prior to formation of the osteoblast (Ducy et al., 1997). Runt-related transcription 
factor 2 is not only a critical gene for the development of intramembranous bone but also 
for endochondral bone formation. 
 The msh homeobox genes 1 and 2 (MSX1 and MSX2) function as transcriptional 
regulators that control cellular proliferation and differentiation during embryonic 
development (Hill et al., 1989).  Together MSX1 and MSX2 have critical roles in 
craniofacial development and, in particular, in the development of the frontal and 
parietal bones.  Cranial mutations of these genes disrupt the tissue-tissue interactions 
among the developing bones (Han et al., 2007).  Both MSX1 and MSX2 are expressed 
when osteogenic differentiation is visible in the frontal primordium, and MSX2 is 
expressed in the parietal primordium. 
Twist homolog 1 (TWIST1) is a basic helix-loop-helix transcription factor that 
organizes the tissue arrangement of cranial mesenchyme (Soo et al., 2002).  Twist 
homolog 1 is strongly expressed in the cranial mesenchyme just beneath the epithelium 
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(Rice et al., 2000).  As the embryo matures, TWIST1 expression becomes more localized 
to the calvarial mesenchyme.  Osteoblasts grow and differentiate in this area and initiate 
the development of the frontal and parietal bones.  Twist homolog 1 becomes localized 
to the osteogenic fronts of these bones and affects suture development. 
To understand early embryonic development of the bovine horn, it will be 
necessary to investigate genes that also contribute to the development of the dermal 
layer, frontal and parietal bones and their sutures.  Our hypothesis is that the gene that 
determines the presence of horns is expressed in osteoprogenitor cells of the early fetus 
and will affect the expression of RUNX2, MSX1, MSX2 and/or TWIST1. 
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3. MATERIALS AND METHODS 
3.1 Fetal Collection and Dissection 
 Bovine fetal samples out of commercial females were collected at the Caviness 
Packing Company in Hereford, Texas for RNA extraction (n = 20) and histological 
analysis (n = 8).  Fetuses were assigned gestational ages of  28 d to 80 d of gestation 
based on crown-rump length (Richardson et al., 1991).  Those that were d 50 and older 
were dissected using the ear, eye, and occipital condyle as reference points.  An incision 
was made with a sterile scalpel between the frontal bones from the nasal bones 
continuing posteriorly to the occipital condyle.  A second incision was made from the 
nasal bones continuing posteriorly just above the eye and ear to meet the first incision at 
the occipital condyle (Appendix A.1). Using sterile scissors and tweezers, 4 tissues 
(frontal bone, parietal bone, skin, and brain) were collected for extraction of RNA and 
directly stored in RNAlater (Invitrogen, Carlsbad, CA) for further processing. 
 For histology, an incision was made between the frontal and nasal bones splitting 
the head in half from the occipital condyle to the nose.  A second incision was made at 
the occipital condyle to remove the head.  For analysis of the top of the head, an incision 
was made just above the ears continuing to the front just above the eyes (Appendix A.2).  
These dissected heads were placed into 4% paraformaldehyde for 12 to 48 hr 
(approximately 24 hr per 1 cm section). 
 For the extraction of RNA from fetuses less than d 50 of gestation, an incision 
was made just behind the occipital condyle cutting through the neck to remove the head.  
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These heads were dissected prior to RNA extraction into the same 4 tissues as listed 
above. For histological analysis, whole fetuses were fixed in 4% paraformaldehyde. 
 To establish the phenotypes of the fetal samples, a set of 44 single nucleotide 
polymorphisms (SNP) were used in a SNPlex assay (Applied Biosystems) to produce 
genotypes for the fetuses (n = 20).  The genotypes were phased using PHASE v2.1 and 
the resultant haplotypes were compared to breed-specific haplotypes for 8 Bos taurus 
breeds for these same markers (Clare Gill, pers. comm.). 
3.2 Histology 
 After fixation in 4% paraformaldehyde for 12 to 48 h, samples were rinsed in 
50% ethanol and then in 70% ethanol for 8 to 24 h each, with final storage in 70% 
ethanol until further processing.  Samples were embedded in paraffin and sections were 
cut to a thickness of 7 µm for histology and in situ hybridization.  Embedding and 
hematoxylin and eosin staining were performed by the Texas A&M Department of 
Veterinary Integrative Biosciences Histology Laboratory. 
3.3 RNA Extraction 
 RNA was extracted in Trizol reagent (Invitrogen, Carlsbad, CA) with the 
addition of 1-Bromo-3-chloro-propane (BCP) (Sigma, St. Louis, MO).  Approximately 
50 to 100 mg of tissue was cut into small pieces using sterile scissors and quickly 
transferred into a pre-chilled mortar containing liquid nitrogen, ground into a fine 
powder with a pre-chilled pestle, then transferred to a 15 ml conical tube containing 2.2 
ml of Trizol.  The tissue was homogenized 6 to 8 times with an 18 gauge needle and a 
sterile syringe, transferred to two 1.5 ml microcentrifuge tubes, and centrifuged at 
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14,000xg for 5 min at 4°C to remove cell debris.  The homogenate was incubated at 
room temperature for 5 min to promote dissociation of nucleoprotein complexes.  The 
supernatant was transferred to a new 1.5 ml tube containing 200 µl BCP, shaken 
vigorously for 15 s, incubated at room temperature for 3 min and centrifuged at 
12,000xg for 10 min at 4°C.  The upper aqueous phase containing RNA was transferred 
to a new 1.5 ml tube containing 200 µl BCP and 400 µl Trizol, shaken vigorously for 15 
s, incubated at room temperature for 3 min and centrifuged at 12,000xg for 10 min at 
4°C.  The upper aqueous phase was again transferred to a new 1.5 ml tube containing 
200 µl BCP, shaken for 15 s, and centrifuged at 12,000xg for 10 min at 4°C.  The 
aqueous layer was then transferred to a new 1.5 ml tube and 1 volume of isopropanol 
was added to precipitate the RNA.  Samples were washed in 70% ethanol, then 
resuspended in nuclease free water. 
 The RNeasy Mini Kit (Qiagen, Valencia, CA) was used to complete purification 
of total RNA according to the manufacturer’s instructions.  Samples were treated with 
27 Kunitz units of DNase 1 on the RNeasy column.  After washing the column with 350 
µl of RW1 Buffer and 500 µl RPE Buffer, 50 µl of RNase-free water was added directly 
to the spin column, and centrifuged at 8,000xg for 1 min to elute the RNA. This was 
repeated using the eluate to increase RNA concentration.  RNA samples were stored at  
-80°C. 
Total RNA was quantified on a Nanodrop ND-1000 spectrophotometer 
(Nanodrop Technologies, Wilmington, DE).  RNA quality for qualitative reverse 
transcriptase polymerase chain reaction (RT-PCR) was assessed by capillary 
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electrophoresis on an RNA 6000 NanoChip with a 2100 Bioanalyzer (Agilent 
Technologies, Palo Alto, California).  Based on Nanodrop concentrations, a nanochip 
was used to assess RNA with concentrations of greater than 100ng/µl, and a picochip 
was used for those with concentrations less than 100ng/µl.  Samples with an RNA 
Integrity Number (RIN) less than 5.0 were excluded. 
3.4 Primer Design 
 Primers for qualitative RT-PCR (Table 3.1) were from Wunderlich (2008).  In 
addition, for quantitative RT-PCR, most of the primers were from Wunderlich (2008).  
In those cases where primer design was required, sequence data available from NCBI 
(http://www.ncbi.nlm.nih.gov) and UCSC Genome Bioinformatics 
(http://genome.ucsc.edu) were used.  Primers were designed using Primer3Plus software 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi).  Criteria were an 
optimal melting temperature of 58°C and maximum of 63°C; self-complementarity of 8 
bases; 3’ end self-complementarity of 6 bases; product length of 50 to 120 base pairs 
(Table 3.2).  Primers were aligned against the bovine (Btau 4.0) or human genome 
sequences using the BLAST algorithm to ensure orthologous genes were being 
investigated.  Primer pairs were also checked using the In silico PCR tool at UCSC to 
verify that they were expected to produce a unique amplicon based on the Btau 4.0 
assembly of the bovine genome sequence. 
3.5 Polymerase Chain Reaction  
 Polymerase Chain Reaction (PCR) was used to optimize primers and to 
determine qualitative analysis of gene expression. Various annealing temperatures 
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Table 3.1. Gene-specific primers used for qualitative RT-PCR
1
 
 
Primer Forward Reverse 
gDNA 
(bp)
2
 
cDNA 
(bp)
3
 
TA 
(°C)
4
 
C21orf45 CGGATTGTTGTGAAGGATGT ACAGCGTAGCAAGATGCAGT 323 323 57 
C21orf59 CCATCATTAGCAGCGAGGAG GGCAAACTTCATCTGGGTCT 425 187 58 
C21orf62 AACAGAGTTTGCTCATCCAC GGCACAGCTACGATATTAGTAA 263 263 55 
C21orf63.1 TGACCATCAGTTGCTAATC GCTGACAATGACTCCATCTT 1825 115 55 
GAPD_quant TTCAACGGCACAGTCAAGG ACATACTCAGCACCAGCATCAC 237 119 60 
HUNK TTGATGGAACATGCCAGAAC TCTGAATCTGCGTGATGAGC 373 373 57 
IFNAR1 GTGGTCATTTATGTTGTGAGC GAAGTGGAAAGGAGTAGATTCC 1357 131 55 
IFNAR2 CTGTCAGTCTGGGTGTTTGC CGTTAGTCCATGCTTGGTGT 177 177 55 
MRAP CATCTGGAGGCAACCCAG CTCCCATCGAGAGGTTCTGT 234 234 58 
OLIG1 GGCGCAAGATCAACAGC CCAGCAGCAGGATGTAGTTG 174 174 60 
SYNJ1 AGTTGCAATACGAATGCTGT TGCTGTCTGATAAGCTCTTTC 470 234 64 
SOX9
5 
TGCTCAAGGGCTACGACTG CGAGATGTGCGTCTGTTCC 788 358 64 
1 
Wunderlich (2008) 
2 
gDNA = Expected size in genomic DNA 
3 
cDNA = Expected size in complementary DNA 
4
 Annealing temperature 
5 
Not in the polled interval but involved in chondrogenesis and osteogenesis 
  
 
1
6
 
Table 3.2. Gene specific PCR primers for real-time RT-PCR 
Role Primer Forward Reverse Size 
(bp) 
Polled Interval C21orf451 GAGCTGGGTGGCGAGTCA TGTTCCTCATTCACAGAAACATTACA 80 
 C21orf591 GGCGCAGCGCATCTG TCATCAGTCAGTCCTTGCATATTAGG 83 
 C21orf621 TGGGCACAGCTTCTTTCTGA CCTCTGAGCTCTGGTGAAGCA 69 
 C21orf661 CATGCCAAACGTCGGATTG CAAGGTGATCTGCCATCTTACCA 68 
 IL10RB1 CACCTTCTGTCCTGTGGATGAC AACGCACATGTAAAGAATTAGCAAGT 57 
 
SFRS151 
CACCTCCACCTCCAGTTAAAGTTT TGGGCAACTGCGGTACAGT 72 
 SYNJ11 GAATGCTGTTCCACACCACAA TTTCGTTCTTTGACTTGGGATTG 54 
Osteogenesis/ 
Chondrogenesis 
BMP4 AACACCGTGAGGAGCTTCCA TGCTGAGGTTAAAGAGGAAACGA 94 
 BMP7.2 AGCTGAGTTCCGCATTTACA AGCTGAGTTCCGCATTTACA 87 
 COL18A11 GATCCATGGGCACTTCTTCAG TCCACCAGCATCTGGTACGT 61 
 
CYR61 
TTACAGTTGGGCTGGAAACT GCTCTGAAGGGGATCTGC 98 
 FGFR2_exon6 CTTTTCCACGTGTTTGATCC TGGAGTTTGTCTGCAAAGTG 68 
 FGFR2_exon7 CACGTATATTCCCCAGCATC CACGTATATTCCCCAGCATC 70 
 FGFR2_exon8 TTCTTGGTCGTGTTCCTCAT CATAGGGGTGTTCTTCATCG 72 
 
FIGF CGCCATCCATTCTCAATTAT AGGACAGAGCTTCTTGGAA 82 
 FOXL21 CTCACGCTGTCCGGCATCT CGTAGAACGGGAACTTGGCTATAAT 52 
 GREM1 TGACCCTCTTCTTCTTGGTG TTTCAGTCCTGCTCCTTTTG 100 
 MSX2 CTGGTCAAACCCTTCGAGAC GAGTATCTGCCCGGTTCC 64 
 PRKAC1 GGACCTGAAGCCAGAGAACCT TTCACACGCTTGGCGAAC 80 
 PTHLH1 AACATCGCTGGAGCTCAACTC CCTGCAATACGTCTTCTGAAGGT 70 
 RUNX11 GGGAGCTGCTTGCTGAAGAT ACAACAAGCCGATTGAGTTAGGA 82 
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Table 3.2 continued. 
Role Primer Forward Reverse Size 
(bp) 
Osteogenesis/ 
Chondrogenesis 
RUNX21 CCAACCCACGAATGCACTATC AGGGACATGCCTGAGGTGACT 66 
 SOX91 AATCTCCTGGACCCCTTCATG GGCGGACAGGCCCTTCT 57 
 STAT11 GCCTCTATCCTGTGGTACAACATG ACAAGGTGGGTTCAGGAAGAAG 68 
 TINP1 ACATGAGCCTTCTTGAAACG TGGCTTTACTCGAAAACCAC 75 
 TWIST11 AGCAGAACCCAAATTCAAAGAAAC TGCCCGTCTGGGAATCAC 92 
 TWIST21 CGACGAGATGGACAATAAGATGAC CACACGGAGAAGGCGTAGCT 75 
 18S1 AGAAACGGCTACCACATCCA CACCAGACTTGCCCTCCA 169 
 YWHAZ1 GCATCCCACAGACTATTT GCAAAGACAATGACAGACCA 120 
1Wunderlich, 2008 
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(50 to 64°C) and magnesium concentrations (1.5 mM to 3.5 mM) were tested to 
optimize primers until a single amplicon was obtained by PCR (40 ng genomic DNA 
template, 0.2 µM forward and reverse primer, 0.12 mM dNTPs, 1U Taq polymerase, 1X 
Buffer (50 mM KCl, 10 mM Tris-HCl, pH 9.0, 0.1% Triton X-100)).  Thermal cycling 
was performed on a MJ PTC-200 (MJ Research, Waltham, MA) thermal cycler (95°C 
for 5 min; 35 cycles at 95°C for 30 sec, and annealing temperatures ranging from 50-
64°C for 30 sec, 72°C for 30 sec; 72°C for 7 min).  Amplicons were separated by size on 
an agarose gel (2% or 3% agarose, 1X TAE, 0.2 µg/ml ethidium bromide) and visualized 
under ultraviolet light (302 nm).  Gels were photographed with a Kodak DC290 digital 
camera and the 1D image analysis software (Eastman Kodak Co., Rochester, NY).  After 
primers were optimized, they were used to survey gene expression qualitatively with 
cDNA as the template. 
3.6 Reverse Transcriptase Polymerase Chain Reaction 
 For qualitative assessment of mRNA, reverse transcription (RT) was performed 
using the SuperScriptTM II Reverse Trancriptase Kit with Oligo(dT) primers (Invitrogen, 
Carlsbad, CA) according to the manufacturer’s instructions.  DNase treated RNA 
samples (500 ng) were used as the template for the reaction.  Following transcription, 2 
µl of the synthesized cDNA was used as template for PCR.  Genomic DNA, an RT 
negative, and a template negative control were also included for each PCR reaction.  
Amplification of GAPDH was used as a positive control.  Amplicons were separated by 
agarose gel (2% or 3% agarose, 1X TAE, 0.2 µg/mL ethidium bromide) electrophoresis, 
visualized under ultraviolet light (302 nm), and photographed using a Kodak DC290 
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digital camera with the 1D image analysis software (Eastman Kodak Co., Rochester, 
NY).  Gene expression was qualitatively determined by the presence or absence of 
amplicons on these agarose gels. 
 For quantitative assessment of mRNA, reverse transcription was performed using 
the SuperScriptTM VILO cDNA Synthesis Kit with random hexamers (Invitrogen, 
Carlsbad, CA) according to the manufacturer’s instructions.  DNase treated RNA 
samples (60 ng) were used as the template for the reaction.  Following transcription, the 
newly synthesized cDNA was diluted 1 to 20 in 25ng/µl of tRNA (Invitrogen, Carlsbad, 
CA).  A 2 µl aliquot of diluted cDNA was used as template for quantitative RT-PCR 
(qRT-PCR) utilizing SYBR GreenER qPCR SuperMix (Invitrogen, Carlsbad, CA).  
Samples were loaded into a 384-well optical PCR plate (catalog # MPS-3898, Phenix, 
Hayward, CA) using an Eppendorf epMotion 5070 robot (Eppendorf, Westbury, NY).  
Plates were then sealed with optical PCR sealing tape (catalog # LMT-OPCT, Phenix, 
Hayward, CA) and loaded onto an ABI 7900HT real-time PCR machine (Applied 
Biosystems, Foster City, CA) for thermal cycling (60°C for 2 min, 95°C for 10 min, 40 
cycles at 95°C for 15 sec and 60°C for 1 min) utilizing SDS 2.3 software (Applied 
Biosystems, Foster City, CA), although analysis was done using SDS 2.2 software.  Due 
to the limited amount of RNA available from the fetal samples, only one biological and 
one technical replicate was used on each plate, and 18S rRNA and YWHAZ were used 
for normalization. 
For primers not previously optimized, RNA was serially diluted in 10-fold 
increments from 0.6 µg/µl to 0.00006 µg/µl, followed by reverse transcription. Realtime 
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qRT-PCR assays were used for further analysis if assay efficiency was within the range 
of 90% to 100% efficient.  Dissociation curve analysis was used to verify presence of a 
single PCR product. 
To assess the existence of sense and antisense transcripts, reverse transcription 
was performed with the SuperScriptTM III First-Strand Synthesis System for RT-PCR Kit 
(Invitrogen, Carlsbad, CA) with gene-specific primers (GSP; Table 3.3) according to the 
manufacturer’s instructions.  DNase treated RNA samples (500 ng) from horn buds (n = 
5) or skin (n = 5) of neonates or 5 mo old calves were used as templates along with 2 µM 
GSP for each reaction.  Forward and reverse GSP were used separately in the reverse 
transcription reaction with the same samples as template to produce sense and antisense 
transcripts.  Complementary DNA was diluted 1 to 10 in DEPC-treated water.  A 3 µl 
aliquot of the diluted cDNA was used as a template for PCR, along with genomic DNA, 
an RT negative, and a template negative control.  Pairs of GSP were used to amplify the 
cDNA.  The presence or absence of a band was visualized under ultraviolet light (302 
nm) after electrophoresis on agarose gel (3% agarose, 1X TAE, 0.2 µg/ml ethidium 
bromide).  Amplicons from cDNA reverse-transcribed from the forward primer 
correspond to an antisense transcript and amplicons derived from reverse-transcription 
with the reverse primer correspond to a sense transcript. 
 
  
 
2
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Table 3.3. Primers for each exon of C21orf661 
 
Primer Forward Reverse Size (bp) TA (°C)
2
 
C21orf66_EXON1_3 GGTAGCTGGGAAAGGGAAAC TCCTCCTCCGAGTCATTCC 199 63 
C21orf66_EXON2 TGAAGAAATCAAGTTACAGCAA GTCGGCAGATGAGTTGAGTT 190 58 
C21orf66_EXON3 CAAAGCAGGTCATGTTAAGGA CCTTTGGCTTTTCTTCTTCC 110 58 
C21orf66_EXON4 GGGAATTGGGAGATTTCACT GGCGTTTCTCATCATCATCT 108 50 
C21orf66_EXON5 TGATGATGACGCTCTGGTAA TATCTGCTCCTGTTCCCATC 67 58 
C21orf66_EXON6 CAATGCCTTATGGTTCATCC GGGAGTTTTGAAAGGGACTG 107 58 
C21orf66_EXON7 CAGGGCCATTGAGAGATTAG ACATACCCTCGCATTTCTTG 81 58 
C21orf66_EXON7alt GCAAGTGTCCTGACAGCATA ACATACCCTCGCATTTCTTG 226 58 
C21orf66_EXON8 AGCTGTACAAACAGCGAGCT AGCTGTACAAACAGCGAGCT 87 58 
C21orf66_EXON8alt AGCTGTACAAACAGCGAGCT GGACTGACTTGAATGGCTTG 95 58 
C21orf66_EXON9 CTCTGATGGCACCAAATCTT ACGTTTGGCATGTTCTTGAT 68 58 
C21orf66_EXON10 TCGTAGACAAGCCAGAGAGC CTTCAAGGTGATCTGCCATC 50 58 
C21orf66_EXON11 GCCTGGCGTTCAAAATACTA TTATGAGGGGGTTGAGCAG 82 58 
C21orf66_EXON12 GCTGTGGTTTGAATCTTTGC CATCGACATCGTCCTTTTCT 68 58 
C21orf66_EXON13 ATGTGGGACCCCTTTTCTAC TTTTCTGCATTCACCACTGA 95 58 
C21orf66_EXON15 AAAAATTCTGGGCCTTACTTG AACTGAAGACCAAAACTGTCG 51 58 
C21orf66_EXON16 GGTATGGCATTTTCTCAAACA TTTTGATGCTGTCATCTCCA 116 58 
C21orf66_EXON17 AGCAGTGGTTCGTGAATCTT CATCAGAGCACCCAATACTG 117 58 
C21orf66_EXON18 GTGTTCGAGCTCTGGATCAT TTCACATTGTGGTCACTTGC 52 58 
1 
Exon 14 was too small to design effective primers, thus this exon was amplified using exon 13 forward and exon 15 reverse 
2
 Annealing temperature 
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3.7 Analysis of Real-Time Reverse Transcriptase Polymerase Chain Reaction 
  Realtime data were analyzed by relative quantification (Livak and Schmittgen, 
2001).  The geometric means of the Ct values for 18S and YWHAZ were used as the 
reference genes for normalization, and the mean of frontal and parietal bone samples 
from polled fetuses was used as the calibrator. 
3.8 Periodic Acid-Schiff Reaction 
 Slides were prepared for staining by melting wax at 55°C for 10 to 15 min.  
Sections were dewaxed using Citrisolv (Fisher, Atlanta, GA) for 5 min 3 times each and 
then hydrated in 100% and 95% ethanol twice for 1 min and then in 70% ethanol for 3 
min.  Slides were rinsed twice in double distilled water for 1 min.  Slides were then 
placed in 0.5% periodic acid (Sigma, St. Louis, MO) for 5 min then rinsed in double 
distilled water twice.  Slides were stained in Schiff’s reagent for 15 min at room 
temperature, and then washed in running tap water for 10 min to develop color.  Slides 
were then stained in Mayer’s Hematoxylin for 2 min and washed in running tap water 
for 2 min to develop color.  Slides were then dehydrated in 70% ethanol for 3 min and 
95% and 100% for 1 min 2 times each.  Slides were in placed in Citrisolv (Fisher, 
Atlanta, GA) for 5 min 3 times.  Slides were mounted in Permount (Fisher, Fair Lawn, 
NJ), coverslipped and allowed to dry overnight. 
3.9 Probe Design 
 Primers were designed to produce amplicons 300 to 500 bp in length, which were 
then optimized using cDNA from tissues known to express the genes of interest (Table 
3.4).  Amplicons were cloned into the PCRII vector using the PCRII dual promoter TA 
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cloning kit (Invitrogen, Carlsbad, CA).  Amplicons were ligated in a 1:1 molar ratio with 
the PCR2 vector at 14°C overnight, transformed into TOP10F’ competent cells by heat 
shock, and plated on LB-agar plates containing 100 µg/ml Ampicillin, 0.05 mg/ml IPTG, 
and 0.04 mg/ml X-gal and grown at 37°C overnight.  White colonies were selected from 
the agar plates and used to inoculate 5 ml LB containing 100 µg/ml Ampicillin. Cultures 
were grown at 37°C overnight with shaking at 250 rpm on a ThermoForma model 420 
orbital shaker (Thermo Electron Corporation, Marietta, OH).  After a 16 to 20 hr 
incubation, 500 µl of culture was mixed with 500 µl 2X freezing solution (72 mM 
K2HPO4, 26 mM KH2PO4, 3.4 mM sodium citrate, 0.8 mM MgSO4, 13.6 mM 
(NH4)2SO4, 8.8% glycerol) to produce a glycerol stock which was stored at -80°C.  A 
dilution of the glycerol stock was used directly in PCR as described above with universal 
PUC forward (GTTTTCCCAGTCACGAC) and reverse 
(CAGGAAACAGCTATGACC) primers to determine orientation of the insert and to 
ensure amplicon identity. 
 The PCR product was purified using Princeton Separations (Adelphia, New 
Jersey) PSIclone HTS 96-well PCR clean-up plate kit as per the manufacturer’s 
instructions. Sequencing reactions were performed using 60 ng of this purified PCR 
product, 0.5 µM PUC forward or reverse primer and 2 µl of Big Dye v1.1 Terminator 
mix (PE Corp. Applied Biosystems, Foster City, California).  The template, primer and 
water were mixed and denatured at 98°C for 2 min, followed by snap cooling on ice for 
2 min.  The Big Dye was then added and the reaction was cycled 25 times at 96°C for 10 
seconds, 50°C for 5 seconds, and 60°C for 4 min. 
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Table 3.4.  Gene specific primers used to develop probes for in situ hybridization 
Primer Forward Reverse 
Size 
(bp) 
C21orf591 GGCTCAACGTCATCAAAGAA GGCAAACTTCATCTGGGTCT 343 
C21orf621 AACAGAGTTTGCTCATCCAC GGCACAGCTACGATATTAGTAA 263 
C21orf661 GATGTCGATGTCGCACTGTT CTGCATTCACCACTGAAGGA 166 
MSX1 GAGTTCTCCAGTTCGCTCAG TGTCAGGTGGTACATGCTGT 300 
RUNX21 CGAAATGCCTCTGCTGTTAT TACTGAGAGTGGAAGGCCAG 322 
SFRS151 AGTTCGTGTATTGAACCTTTG GGTACAGTTGGTACAGAGTTTG 201 
SOX91 TGCTCAAGGGCTACGACTG CGAGATGTGCGTCTGTTCC 358 
TWIST11 TCCAGAGAAGGAGAAAATGG GTCCATAATGATGCCTTTCC 360 
1 Wunderlich (2008) 
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Dye terminator and salts were removed from the sequencing reactions using Qiagen’s 
DyeEx kit as per the manufacturer’s instructions. Cleaned sequences were dried down, 
resuspended in 10 µl di-formamide and loaded onto an ABI 3130xl (Applied 
Biosystems, Foster City, California) using 50 cm capillaries and POP7 polymer with an 
injection rate of 1.6kV for 15 s, and electrophoresed at 8.5kV. 
 Plasmid DNA was isolated using the Plasmid Maxi-kit (Qiagen, Valencia, CA) 
according to the manufacturer’s instructions.  Plasmid DNA (~20 µg) was digested with 
50 U BamHI (Promega, Madison, WI) or EcoRV (Promega, Madison, WI) at 37°C 
overnight.  After digestion, an equal volume of phenol:chloroform:isoamyl alcohol 
(25:24:1) was added to the digest, vortexed, and centrifuged at 8000xg for 5 min.  The 
upper aqueous phase was removed to a clean tube and an equal volume of chloroform 
was added, vortexed, and centrifuged at 8000xg.  The upper aqueous phase was 
transferred to a clean tube and DNA was precipitated with 1/10 volume 2M NaCl and 
2.5 volumes of absolute ethanol at -80°C for 1 hr.  Samples were centrifuged at 13000xg 
for 10 min, rinsed with 70% ethanol, air dried and then re-suspended in 50 µl sterile 
water.  DNA was quantified on a Nanodrop ND-1000 spectrophotometer (Nanodrop 
Technologies, Wilmington, DE) and run on an agarose gel (1% agarose , 1X TAE, 0.2 
µg/ml ethidium bromide) to ensure complete digestion. 
3.10 Labeling with Digoxigenin 
 Probes for in situ hybridization were labeled with digoxigenin-UTP by in vitro 
transcription using the DIG RNA Labeling (SP6/T7) kit (Roche, Indianapolis, IN) 
according to the manufacturer’s instructions.  The T7 promoter was used for BamHI 
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digests and SP6 promoter for EcoRV digests to obtain antisense and sense probes 
dependent on the orientation of the insert.  Probes were purified using Centri-Sep 
columns (Princeton Separations, Inc., Adephia, NJ).  Dot blots were used to the 
determine labeling efficiency of the probes (Roche, Indianapolis, IN) by immunological 
detection using the Roche DIG Nucleic Acid Detection kit (Roche, Indianapolis, IN) in 
accordance with the product manual, except volumes were reduced to 10 to 20 ml 
dependent on the size of the blot.  Based on these results, probes were diluted to a 
working concentration of 10 ng/µl. 
3.11 In situ Hybridization with Poly d(T) 
 The mRNA integrity of the sections was verified by the use of a Poly d(T) Probe 
and NovocastraTM Detection Kit (Leica Microsystems, United Kingdom).  Slides were 
prepared for hybridization by melting wax at 55°C for 10 to 15 min.  Sections were then 
dewaxed using Citrisolv (Fisher, Atlanta, GA) 2 times for 3 min each and then hydrated 
in 100% ethanol twice for 3 min and in 95% ethanol once for 3 min.  Slides were then 
rinsed in DEPC-treated water for 3 min, covered with 100 µl of 5 µg/ml of Proteinase K 
(0.05 M Tris-HCL pH7.6) and incubated for 30 min at 37°C.  Slides were then rinsed 
twice in DEPC-treated water for 3 min and then dehydrated in 95% and 100% ethanol 
for 3 min each.  Slides were allowed to air dry before adding 20 µl of the probe 
hybridization solution from the kit.  Sections were then coverslipped, placed in a humid 
chamber at 65°C for 15 min, and allowed to incubate at 37°C for 2 hr.  Sections were 
then washed in TBS (50 mM Tris-HCl pH 7.6, 150 mM NaCl) containing 0.1% Triton 3 
times for 3 min each.  Slides were placed on an incubation tray and covered with 100 µl 
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of blocking solution (normal rabbit serum diluted 1:5 in TBS, 3% w/v BSA, 0.1% v/v 
Triton) for 10 min.  Blocking solution was tipped off and sections were covered with 
100 µl of 1:200 antibody solution (Rabbit F(ab’) anti-FITC in TBS, 3% w/v BSA, 0.1% 
v/v Triton) for 30 min.  Slides were washed twice in TBS for 3 min and in alkaline 
phosphatase substrate buffer (0.1 M Tris-HCl, pH 9.5, 0.1 M NaCl, 50 mM MgCl2) for 5 
min.  Sections were covered in 100 µl of color solution from the kit, coverslipped, sealed 
with rubber cement, and placed in a humid chamber protected from light overnight.  
Coverslips were removed and slides were washed in running tap water for 5 min and 
mounted with Clear Mount (Electron Mircoscopy Sciences, Hatfield, PA).  The integrity 
of mRNA was determined by viewing sections with and without probe under bright field 
on a Nikon Eclipse E1000 microscope to evaluate the intensity of purple staining due to 
hybridization of the poly d(T) probe to polyA mRNA. 
3.12 In situ Hybridization Using Digoxigenin-Labeled Probes 
 Slides were prepared for hybridization by melting wax at 55°C for 10 to 15 min.  
Sections were then dewaxed in 3 changes of Citrisolv (Fisher, Atlanta, GA) for 5 min 
each with agitation every 2 to 3 min.  Rehydration was done through a series of 100%, 
95%, and 70%, ethanol washes; each wash was for 2.5 min and repeated twice.  Sections 
were then rinsed in DEPC-treated water for 2 min each, then twice in DEPC-1X PBS for 
5 min and treated in DEPC-1X PBS with 0.3% Triton X-100 (Fisher, Atlanta, GA) for 
15 min.  Sections were then rinsed twice in DEPC-1X PBS for 5 min and permeabilized 
in 5 µg/ml proteinase K in TE for 10 min.  Sections were post fixed in DECP-1X PBS 
with 4% paraformaldehyde at 4°C for 5 min, and then rinsed twice in DEPC-1X PBS for 
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5 min.  Sections were then treated twice in DEPC-1X PBS with 100 mM glycine for 3 
min and then rinsed twice in DEPC-1X PBS for 5 min.  Sections were acetylate treated 
in 0.1 M TEA plus 0.25% v/v acetic anhydride twice for 5 min and rinsed twice in 
DEPC-1X PBS for 5 min.  Slides were incubated at 37°C for 1 hr in pre-hybridization 
solution (50% formamide, 4X SSC).  Sections were covered with 60 µl of hybridization 
buffer (40% deionized formamide, 10% dextran sulfate, 1X Denhardt’s solution, 4X 
SSC, 10 mM DTT, 1 mg/ml yeast t-RNA, 1 mg/ml denatured and sheared salmon 
sperm) containing 10 ng DIG-labeled RNA probe.  These sections were then 
coverslipped, sealed with rubber cement, and placed into a humid chamber at 50°C or 
55°C overnight, depending on the probe.  Coverslips were removed by immersing slides 
into 2X SSC for 5 min at room temperature, and then washed twice in 2X SSC for 15 
min with shaking at 37°C.  Single-stranded RNA was then digested in NTE buffer (500 
mM NaCl, 10 mM Tirs pH 8.0, 1 mM EDTA) containing 20 µg/ml RNase A for 30 min 
at 37°C, followed by 2 washes in 1X SSC for 15 min with shaking at 37°C.  Sections 
were washed in buffer 1 (100 mM Tris-HCl pH 7.5, 150 mM NaCl) at room temperature 
for 5 min, followed by adding 100 µl of blocking solution (buffer 1 containing 0.1% 
Triton, 2% normal sheep serum) directly to each section for 15 to 30 min.  Blocking 
solution was decanted and sections were covered with 75 µl of 1:500 antibody solution 
(buffer 1 containing 0.1% Triton, 1% normal sheep serum, 0.15 U anti-DIG alkaline 
phosphatase per section), coverslipped and placed in a humid chamber for 2 hr at room 
temperature.  Coverslips were then removed and sections were washed twice in buffer 1 
for 10 min, and then twice in detection buffer (0.1 M Tris-HCL pH 9.5, 0.1 M NaCl, 50 
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mM MgCl2) for 10 min.  Sections were then covered with 75 to 100 µl color solution (1 
ml detection buffer, 20 µl Roche NBT/BCIP solution, 1 mM levamisole), coverslipped, 
sealed with rubber cement, and placed in a humid chamber overnight protected from 
light.  Slides were washed and coverslips removed in buffer 3 (10 mM Tris-HCl pH 8.1, 
1 mM EDTA) for 5 min, and then rinsed in water for 2 min.  Sections were then 
mounted with Clear Mount (Electron Mircoscopy Sciences, Hatfield, PA) and allowed to 
dry. 
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4. RESULTS AND DISCUSSION 
4.1 Qualitative Analysis of Gene Expression 
 The horn bud in cattle appears at d 60 of gestation (Evans and Sack, 1973).  In 
order to refine the list of candidate genes for horn bud formation, the presence or 
absence of expression of genes from the polled interval (IFNAR to SOD1) was 
characterized in bovine fetal frontal bone, parietal bone, skin, and brain samples ranging 
from d 35 to 75 of gestation (Tables 4.1 - 4.4).  Initially, we intended to survey all 19 of 
the genes from the polled interval in this way (based on Table 4.1 in Wunderlich, 2008), 
but limited amounts of RNA from the fetal samples led us to change strategy and switch 
to characterization of expression of a subset of genes by quantitative RT-PCR (Section 
4.2, below). 
 As expected, all tissues expressed GAPDH, which was used as a positive control, 
and SOX9, which is involved in chondrogenesis and osteogenesis. Also as expected, 
OLIG1 was only expressed in the brain (Table 4.1).  However, expression of OLIG1 was 
not observed in brain samples from d 50 and d 55 of gestation. C21orf63, which is an 
uncharacterized protein coding gene, exhibited the same expression profile as OLIG1 in 
the brain (as well as being expressed in the other tissues).  Oligodendrocyte transcription 
factors 1 and 2 are known to promote oligodendrocyte formation in the central nervous 
system and Cheng et al. (2007) recently showed that bone morphogenetic proteins 
(BMP) 2 and 4 repress OLIG1 and OLIG2, which inhibits oligodendrocyte 
differentiation.  Therefore, it is possible that between d 50 and 55 of gestation, BMP 
signaling is enhanced, thus inhibiting OLIG1 expression but future studies would be 
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necessary to verify this hypothesis.  Because OLIG1 expression was limited to the brain, 
it was not pursued further in the current study. 
 All of the other tested genes from the polled interval were expressed in each of 
the tissues at most of the fetal developmental time points sampled.  This is in contrast to 
the results of Wunderlich (2008), which showed by qualitative RT-PCR that expression 
of IFNAR1, IFNAR2, C21orf62, C21orf63, MRAP, C21orf45, and HUNK was not 
detectable in skin and bone samples from neonates.  In neonates, SYNJ1 was only 
detected in horned samples. 
4.2 Real-Time Reverse Transcriptase PCR 
Wunderlich (2008) concluded that IL10RB, SFRS15, C21orf66, OLIG1, OLIG2, 
and HUNK were candidates for the polled locus based on their expression patterns in 
neonates and 5 to 6 mo old calves.  In the current study, relative levels of expression of 3 
of these genes (IL10RB, SFRS15, and C21orf66), plus 4 genes (C21orf45, C21orf59, 
C21orf62, and SYNJ1) from the qualitative study described in Section 4.1 were 
characterized by real-time quantitative RT-PCR in bovine fetal frontal and parietal 
bones.  RNA extractions from the majority of the skin samples and some brain samples 
had RIN < 5.0 and were not of sufficient quality to use for quantitative RT-PCR. 
To compare relative levels of expression between samples representing the 
horned and polled phenotypes, we attempted to classify the fetuses based on breed-
specific SNP haplotypes.  Unfortunately, because most of the cows were probably 
crossbreds, phenotypes could only be definitively established in a few cases. 
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Table 4.1. Qualitative assessment of gene expression in bovine fetal brain 
 
 Days of Gestation1 
Gene2 35 40 45 50 55 60 65 70 75 
C21orf45 + + + + + + + + + 
C21orf59 + + + + + + + + + 
C21orf62 + + + + + + + + + 
C21orf63 + + + - - + + + + 
HUNK + + + + + + + + + 
IFNAR1 + + + + + + + + + 
IFNAR2 + + + + + + + + + 
MRAP + + + + + + + + + 
OLIG1 + + + - - + + + + 
SYNJ1 NA + - NA NA + + NA NA 
SOX9 NA + + NA NA + + + + 
1 NA = No data available because of limited RNA for samples from these time points 
2 All genes except SOX9 are from the polled interval. SOX9 is involved in 
chondrogenesis and osteogenesis. 
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Table 4.2. Qualitative assessment of gene expression in bovine fetal frontal bone 
 Days of Gestation1 
Gene2 35 40 45 50 55 60 65 70 75 
C21orf45 + NA + NA NA + + + NA 
C21orf59 + NA + NA NA + + + NA 
C21orf62 + NA + + NA + + + NA 
C21orf63 + + + + - + + + - 
HUNK + - + NA NA + + + NA 
IFNAR1 + NA + + + + + + + 
IFNAR2 + NA + + + + + + + 
MRAP + NA + NA NA + + + + 
OLIG1 - - - - - - - - - 
SYNJ1 + NA + NA NA NA NA NA NA 
SOX9 + NA + NA NA - + NA NA 
1 NA = No data available because of limited RNA for samples from these time points 
2 All genes except SOX9 are from the polled interval. SOX9 is involved in 
chondrogenesis and osteogenesis. 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Table 4.3. Qualitative assessment of gene expression in bovine fetal parietal bone 
 
 Days of Gestation1 
Gene2 35 40 45 50 55 60 65 70 75 
C21orf45 + NA + NA NA + + + NA 
C21orf59 + NA + NA NA + + + NA 
C21orf62 + NA + + + + + + + 
C21orf63 + + + + - + + - - 
HUNK + - + NA NA + + + NA 
IFNAR1 + NA + + + + + + + 
IFNAR2 + NA + + + + + + + 
MRAP + NA + NA NA + + + + 
OLIG1 - - - - - - - - - 
SYNJ1 + NA + NA NA + + NA NA 
SOX9 + NA + NA NA + + NA NA 
1 NA = No data available because of limited RNA for samples from these time points 
2 All genes except SOX9 are from the polled interval. SOX9 is involved in 
chondrogenesis and osteogenesis. 
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Table 4.4. Qualitative assessment of gene expression in bovine fetal skin 
 
 Days of Gestation1 
Gene2 35 40 45 50 55 60 65 70 75 
C21orf45 + NA + NA NA + + + + 
C21orf59 + NA + NA NA + + + + 
C21orf62 + NA + + - + + + + 
C21orf63 + + + - + + - - + 
HUNK + - + NA NA + + - + 
IFNAR1 + NA + + + + + + + 
IFNAR2 + NA + + + + + + + 
MRAP + NA + NA NA + + + + 
OLIG1 - - - - - - - - - 
SYNJ1 + NA + NA NA + + NA NA 
SOX9 + NA + NA NA + + + + 
1 NA = No data available because of limited RNA for samples from these time points 
2 All genes except SOX9 are from the polled interval.  SOX9 is involved in 
chondrogenesis and osteogenesis. 
 
 
 
 
36 
Among the fetuses collected, 2 were classified as polled (2.55 and 5.70) and 2 horned 
(5.55 and 1.70), while phenotypic classification of the remaining samples based on their 
genotypes was inconclusive.  Therefore, the real-time RT-PCR results presented in 
Figures 4.1 to 4.3 must be treated as descriptive only because they are based on a single 
biological sample for each phenotype from each time point (d 55 and 70 of gestation). 
 Expression of SYNJ1 was not detected in the samples evaluated.  Given that 
expression of SYNJ1 was observed in the qualitative study (Section 4.1), it may be 
necessary to redesign the primers used for real-time analysis to confirm this negative 
result.  Similarly, C21orf45 and C21orf62 were not evaluated because amplification was 
inconsistent and these primers would need to be redesigned to characterize expression of 
these genes. 
C21orf59, C21orf66, IL10RB, and SFRS15 (Figure 4.1) from the polled interval 
and BMP4, TWIST1, RUNX1, and RUNX2 (Figure 4.2), which have known roles in 
osteogenesis, showed a general trend that as age increased from d 55 to 70 of gestation, 
the levels of expression increased in the frontal and parietal bones of fetuses genotyped 
as horned.  In the horned samples, expression of genes from the polled interval tended to 
be higher in the frontal bone than in the parietal bone, whereas the converse was 
observed for TWIST1, RUNX1 and RUNX2 and there was no difference in the level of 
expression of BMP4.  Expression of MSX2 and SOX9 in the parietal bone also increased 
from d 55 to d 70 (Figure 4.3).  There was little variation in the levels of TWIST2, except 
in the frontal bone at d 70 where there was 5.2 fold higher expression in the horned
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Figure 4.1. Relative levels of expression of genes from the polled interval.  Expression was measured in samples from the 
frontal (FB) and parietal bones (PB) of horned and polled fetuses at d 55 and 70 of gestation.
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Figure 4.2. Relative levels of expression of genes with known roles in osteogenesis. Expression was measured in samples from 
the frontal (FB) and parietal bones (PB) of horned and polled fetuses at d 55 and 70 of gestation. 
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Figure 4.3. Relative levels of expression of genes with known roles in osteogenesis and chondrogenesis. Expression was 
measured in samples from the frontal (FB) and parietal bones (PB) of horned and polled fetuses at d 55 and 70 of gestation. 
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sample than the polled sample.  Forkhead box L2 was more strongly expressed in the 
parietal bone than frontal bone and polled samples had higher levels of expression of 
FOXL2 than horned samples.  However, in the horned samples, expression was 11.4 fold 
higher in the parietal bone at d 55 than at d 70 (Figure 4.3). 
 Because of the limited number of samples for which the horned or polled 
phenotypes could be assigned, and since the frontal and parietal bones consist of a 
variety of cell types at the developmental time-points sampled, conclusions are difficult 
to draw based solely on these real-time RT-PCR data.  It may be necessary to use laser 
capture microdissection in future studies to characterize the levels of expression of genes 
in specific cell types.  In this study, in situ hybridization (section 4.4) was used as a more 
specific measure of when, and in which populations of cells, the genes were expressed. 
4.3 Microscopic Observation of Periodic Acid-Schiff Reaction 
 As intramembranous ossification occurs, embryonic mesenchyme becomes the 
vascularized connective tissue of the periosteum or the pericranium, which covers the 
outer surface of the skull bones (Figure 4.4).  The pericranium is made up of 2 layers; 
the fibrous layer and the osteogenic layer.  The osteogenic layer contains progenitor cells 
that develop into osteoblasts, which give rise to bone matrix leading to the subsequent 
development of trabecular bone. 
At d 55 and 60 of gestation, the Periodic Acid-Schiff reaction outlined the frontal 
and parietal bones, evidenced by the dark pink staining in the pericranium of both bones 
(Figure 4.4).  The clear outline of the 2 bones allowed visualization of the coronal 
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BR 
FB 
PB 
CS 
TB 
P 
B. 
A. 
 
 
Figure 4.4.  Periodic Acid-Schiff reaction in the frontal and parietal bones at the coronal 
suture at d 55 and 60.  Cytoplasm, pericranium, trabecular bone, and osteoblasts are 
stained pink and the nuclei are stained blue.  A. Fetus (2.55) genotyped as homozygous 
polled at d 55.  The frontal bone is smooth and flat at the coronal suture as shown by the 
pericranium in dark pink.  B. Heterozygous fetus (7.60) at d 60.  The frontal bone is 
curved like a crescent at the coronal suture also shown by the pericranium in dark pink.  
FB = frontal bone, PB = parietal bone, CS = coronal suture, P = pericranium, TB = 
trabecular bone, BR = brain. (4X) 
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suture.  Horns grow on the frontal bone adjacent to the coronal suture that is between the 
frontal and parietal bones, suggesting the suture may have a role in horn development. 
Trabecular bone can also be seen within the pericranium.  Osteoblasts lining the 
outside of the trabecular bone, as well as osteocytes within, can be observed.  The 
Periodic Acid-Schiff reaction allowed identification of specific cell types within regions 
of interest.  This provided an anatomical guide for evaluation of the localization of gene 
expression by in situ hybridization. 
4.4 In situ Hybridization 
 In situ hybridization was conducted on fetal sections that ranged from d 40 to 80 
of gestation in 5 day increments.  Probes were for C21orf59, C21orf62, C21orf66, and 
SFRS15 from the polled interval, as well as MSX1, RUNX2, SOX9 and TWIST1 that have 
known roles in osteogenesis, chondrogenesis and suture development.  Whereas overall 
temporal and spatial expression patterns differed for each gene, an unexpected result was 
that all 4 of the genes from the polled interval were detected in active osteoblasts 
surrounding newly formed bone, suggesting that each of the genes has a role in 
intramembranous bone formation. 
 Examination of whole mounts revealed expression of RUNX2 and an antisense 
transcript of C21orf66 in the developing frontal bone at d 40 and 45, respectively (Figure 
4.5).  Expression of C21orf59, C21orf62, MSX1 and TWIST1, in patterns similar to 
RUNX2, was also detected at d 45 (data not shown).  Expression of RUNX2 was limited 
to osteoprogenitors and osteoblasts, whereas Anti-C21orf66 was also detected in 
mesenchymal cells.  However, it was difficult to maintain the integrity of the dermal 
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Figure 4.5. In situ hybridization of developing mesenchyme at d 40 and 45.  A. RUNX2; 
(40X) B. Anti-C21orf66; (100X). Localization of signal to mesenchymal, 
osteoprogenitor and osteoblast cells is indicated by arrows.  
RUNX2 
d 40 
A. 
Anti‐C21orf66 
d 45 
B. 
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layer in these experiments, and pairs of antisense and sense slides were not obtained.  To 
improve integrity of the sections at these early stages, thicker sections may be needed.  
Nevertheless, based on this observed expression in the mesenchyme (rather than 
osteoblasts), C21orf66 and/or its antisense transcript become the most likely candidate 
for the polled locus. 
 As previously shown in Figure 4.4, the frontal bone, near the coronal suture, is 
curved like a crescent at d 60, which coincides with when the horn bud appears.  This 
region was evaluated for each of the genes (Figure 4.6 - 4.12). 
 Runt-related transcription factor 2 was abundantly expressed at d 60, whereas 
SOX9 was barely detectable (Figure 4.6).  Expression of RUNX2 and SOX9 was 
localized to the osteoblasts lining the trabecular bone within the frontal bone and RUNX2 
was also expressed in the developing mesenchyme and along the osteogenic layer of the 
pericranium. 
  Runt-related transcription factor 2 determines the osteoblastic lineage of 
mesenchymal cells (Otto et al., 1997) and regulates osteoblastic proliferation (Lana-
Elola et al., 2007), whereas SOX9 has a well-characterized role in chondrogenesis (Bi et 
al., 1999) and has also been shown to have a role in early osteogenesis (Yamashiro et al., 
2004).  The coordinate expression of these genes is crucial for the development of the 
cranium.  Abundant expression of RUNX2 is not unexpected due to its role in controlling 
osteoblast maturation and is consistent with the results of Holleville et al. (2007) in E12 
chick embryos. 
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 A. 
B. 
Figure 4.6.  Brightfield micrographs of the localization of RUNX2 and SOX9 in 
frontal bone at d 60 of gestation.  A-B. Hybridization of digoxygenin-labeled 
antisense probes to sense transcripts.  C-D. Sense controls.  A, C. RUNX2. 
Expression was detected in osteoblasts and mesenchyme along the osteogenic 
layer of the pericranium. B, D. SOX9. Expression was observed in the 
osteoblasts lining the trabecular bone.  OB = osteoblasts, TB = trabecular bone, 
OL = osteogenic layer. (40X) 
OB 
OL 
OB 
TB 
TB 
C. 
D. 
RUNX2 
Antisense 
 
SOX9 
Antisense 
 
RUNX2 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SOX9 
Sense 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 In addition to their roles in craniofacial bone formation, RUNX2 and SOX9 are 
critical for the development of endochondral bones (Stein et al., 2004).  For example, 
expression of SOX9 was detected in cartilage of the developing knee, foot, spinal 
column, and rib cage at d 40 and 45 of gestation but there was no evidence of expression 
in cartilage from the head (data not shown). 
  At d 55, 60, 75 and 80 of gestation, the transcription factors MSX1 and TWIST1 
were abundantly expressed in developing mesenchyme, osteoblasts, and osteocytes of 
the frontal and parietal bones (Figure 4.7), which is consistent with results of Yoshida et 
al. (2005), Han et al. (2007), and Connerney et al. (2008).  These genes were evaluated 
because they are known to have roles in the development of the osteogenic fronts 
associated with the coronal suture between the frontal and parietal bones (Ishii et al., 
2003; Antonopoulou et al., 2004).  Expression of both genes was also detected in the 
orbital bone (Figure 4.8). 
 Expression that was restricted to the developing mesenchyme, osteoblasts, and 
osteocytes was also detected using the MSX1 sense control probe.  This result can be 
explained because MSX1 is known to have an antisense transcript that is thought to be 
involved in autoregulation of the sense transcript (Petit et al., 2009).  It is also important 
to note that while the general levels of expression were similar based on the intensity of 
hybridization signal, there was a difference in distribution of expression with MSX1 
appearing to be more highly expressed in the mesenchyme toward the suture than 
TWIST1.
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B. 
Figure 4.7. Brightfield micrographs of the localization of bidirectional 
transcripts of MSX1 and TWIST1 in frontal bone at d 60 of gestation. A-C. 
Hybridization of digoxygenin-labeled antisense probes to sense transcripts. D-
F. Sense controls.  A, B. MSX1. Expression was detected in developing 
mesenchyme (asterisk), osteoblasts and osteocytes.  D, E. Anti-MSX1. The 
antisense transcript co-localized with the sense transcript. C, F. TWIST1. 
Expression was observed in developing mesenchyme, osteoblasts and 
osteocytes. OB = osteoblasts, OC = osteocytes, TB = trabecular bone. (40X) 
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OB 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* 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 Antisense 
Orbital bone 
OB 
Sense 
OB 
Figure 4.8. Brightfield micrographs of the localization of bidirectional transcripts 
of MSX1 in orbital bone at d 55 of gestation. A. Hybridization of digoxygenin-
labeled antisense MSX1 probe to sense transcripts. B. Anti-MSX1. Expression was 
detected in the osteoblasts. (40X) 
A.  B. 
d 55 
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Figure 4.9. Brightfield micrographs of the localization of C21orf59 and 
C21orf62 in frontal bone at d 60 of gestation. A-B. Hybridization of 
digoxygenin-labeled antisense probes to sense transcripts. C-D. Sense 
controls.  A, C. C21orf59. Expression was detected in the osteoblasts lining 
the trabecular bone and extending into the mesenchyme along the osteogenic 
layer. B, D. C21orf62. Expression was observed in osteoblasts lining the 
trabecular bone. OL = osteogenic layer, OB = osteoblasts. (40X) 
C21orf59 
Antisense 
 
A. C21orf59 
Sense 
C21orf62 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Figure 4.10. Brightfield micrographs of the localization of bidirectional transcripts of 
C21orf66 and SFRS15 in frontal bone at d 60 of gestation. A-B. Hybridization of 
digoxigenin-labeled antisense probes to sense transcripts. C-D. Sense controls.  A. 
C21orf66. Expression was detected in developing mesenchyme along the osteogenic 
layer of the pericranium and in osteoblasts lining the trabecular bone.  C. Anti-C21orf66. 
Expression of the antisense transcript appeared to co-localize with the sense transcript. 
B, D. SFRS15. Expression was observed in developing mesenchyme, osteoblasts and 
osteocytes. OL = osteogenic layer, OB = osteoblasts, OC = osteocytes.  (40X) 
B. 
C21orf66 
Sense 
SFRS15 
Sense 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OB 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OL 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OL 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 Both C21orf59 and C21orf62 were expressed in the osteoblasts of the frontal 
bone in a pattern that appears to line the trabecular bone (Figure 4.9).  In addition, 
expression of C21orf59 extended to the developing mesenchyme along the osteogenic 
layer, but there was minimal expression of C21orf62 in the mesenchyme.  At d 80, 
C21orf62 was also expressed in the osteoclasts of the frontal bones (data not shown).  
There was no evidence of expression of C21orf59 or C21orf62 in endochondral bone 
formation. 
 Expression of C21orf66 was detected in osteoblasts and developing mesenchyme 
along the osteogenic layer of the pericranium and SFRS15 was detected in 
osteoprogenitors, osteoblasts osteocytes (Figure 4.10). However, based on the intensity 
of hybridization signals, the relative levels of expression of C21orf66 and SFRS15 were 
lower at d 60 than C21orf62 and C21orf59. 
 Expression of C21orf66 and SFRS15 was also detected in developing 
endochondral bone.  At d 40 and 55, there was abundant expression of both genes within 
the cartilage of the femur, knee, and ear.  At d 55, expression in the ear was specifically 
localized to areas of hyaline cartilage for both genes and there appeared to be a gradient 
of expression with less signal detected in regions distal to the cartilage (Figures 4.11 and 
4.12). 
 Colocalization of these 4 genes from the polled interval in developing 
intramembranous bones suggests that all of these genes have a role in cranial facial bone 
development.  Both C21orf66 and SFRS15 may also have roles in endochondral 
ossification.  Given their close proximity on BTA1, it may be that these genes are 
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Figure 4.11. Brightfield micrographs of the localization of bidirectional 
transcripts of C21orf66 in cartilage. A-C. Hybridization of digoxygenin-
labeled antisense probes to sense transcripts. C-E. Detection of antisense 
transcripts with sense probes.  A, D. Expression in the hyaline cartilage of the 
developing knee at d 40 of gestation (40x).  Brackets indicate a gradient in 
expression.  B, E. Expression in the elastic cartilage of the ear at d 45 (40x). C, 
F. Expression in the elastic cartilage of the ear at d 55 (100x). HC = hyaline 
cartilage, EC= elastic cartilage. 
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Figure 4.12. Brightfield micrographs of the localization of SFRS15 in 
cartilage. A-B. Hybridization of digoxygenin-labeled antisense probes to sense 
transcripts. C-D. Sense control.  A, C. Expression in the hyaline cartilage of 
the femur at the edge of the hypertrophic celss at d 45 of gestation.  Brackets 
indicate a gradient in expression.  B, D. Expression in the elastic cartilage of 
the ear at d 55. C, F. Expression in the elastic cartilage of the ear at d 55. 
(40x). HC = hyaline cartilage, EC= elastic cartilage.  
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d 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coordinately regulated in some way.  To the best of our knowledge, this is the first time 
that in situ hybridization data have suggested a role for any genes from the polled 
interval in bone development in any species. 
4.5 Identification of Bovine C21orf66 Antisense Transcripts 
 Data collected by in situ hybridization were indicative of expression of an 
antisense transcript covering at least exons 12 and 13 of C21orf66 in developing 
intramembranous and endochondral bone from d 45 to 55, and this had not previously 
been described for this gene in cattle.  These data were verified by RT-PCR using cDNA 
from neonates synthesized with a gene-specific primer (C21orf66F; Table 3.2).  There 
was also some evidence of an antisense transcript in the Genbank database in which 
there are 20 expressed sequences tags (EST) on the minus strand covering exons 12 to 
18 and the 3’ untranslated region of C21orf66.  Presence of an antisense transcript for 
bovine C21orf66 is also consistent with the finding by Huang et al. (2007), who 
demonstrated that there is an antisense transcript in human liver cells.  As a result of 
confirming the presence of a C21orf66 antisense transcript, the next objective was to 
determine the extent to which the Anti-C21orf66 transcript was complementary to the 
C21orf66 transcript. 
 Wunderlich (2008) predicted the existence of 2 C21orf66 transcripts due to 
alternative splicing of exons 7 and 8 involving 131 bp from the end of intron 6 and 17 bp 
from the start of intron 9, respectively.  To characterize the sense and antisense 
transcripts it was critical that gene-specific primers were utilized to synthesize cDNA 
because synthesis with random hexamers created a mixture of transcripts from both 
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strands.  Amplification of each exon (or multiple exons simultaneously) was attempted 
from cDNA for the sense and antisense transcripts.  The very high GC content of the 5’ 
untranslated region and exon 1 made primer design difficult for that region.  Sequence 
was obtained for exon 1 for the sense transcript but amplification failed from antisense 
cDNA.  It was established that there are 2 sense transcripts for C21orf66.  There was no 
evidence of the alternate exon 7 predicted by Wunderlich (2008) in the sense transcript.  
However, this alternate exon was present in the antisense transcript.  There was also 
evidence of 2 antisense transcripts, one involving both alternate exon 7 and alternate 
exon 8 and the other involving just alternate exon 7.  Although no sequence was 
produced for exon 18, this exon is represented in the antisense EST in Genbank.  Gene 
models for the sense and antisense transcripts for bovine C21orf66 are shown in Figure 
4.13. 
 Sequences from the transcripts were aligned to genomic sequences produced by 
Wunderlich (2008) utilizing a panel of animals from horned and polled breeds.  No new 
sequence variants were identified. 
 The sequence data collected suggest that the antisense transcript likely 
corresponds to the full sense transcript, with the exception of exons 7 and 8.  The extent 
to which full-length natural antisense transcripts exist and their specific regulatory roles 
has yet to be widely reported (Kramer et al., 2003; Chen et al., 2005; Petit et al., 2009).  
Co-expression in the same cells, as was observed for C21orf66, and/or an inverse 
relationship between sense and antisense accumulation is indicative of regulation by the 
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Figure 4.13.  Map of exons in the C21orf66 sense and antisense transcripts.  Numbered boxes indicate the location of exons 
and sequence was generated for those that are solid red. A. Sense transcript. B. Alternate sense transcript. C. Antisense 
transcript. D. Alternate antisense transcript.  Alternate transcripts are due to alternative splicing of exons 7 and 8. 
 
 
 
57 
antisense transcript (Chen et al., 2005).  One example of a gene for which a fully 
complementary antisense transcript exists is canine erythropoietin receptor (EPO-R), and 
coordinate regulation of the sense and antisense EPO-R transcripts appears to be critical 
for lung growth (Zhang et al., 2008).   
 In this study, MSX1 was shown to have an antisense transcript in cattle.  This is 
similar to MSX1 in mice, rats, and humans, for which an antisense transcript covering 
exon 2 of the sense transcript and part of the intron is expressed in differentiated bone 
and the balance of the levels of the 2 transcripts is related to the expression of MSX1 
protein (Blin-Wakkach et al., 2001). 
 The role of the sense and antisense transcripts of C21orf66 in intramembranous 
bone formation could be elucidated in vitro by perturbating the relative levels of the 
complementary transcripts and monitoring subsequent up- or down-regulation of other 
genes that are critical for bone formation. 
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5. SUMMARY AND CONCLUSIONS 
 
The objective of this study was to conduct a survey of gene expression in bovine 
fetal samples at various stages of development for genes in the region on bovine 
chromosome 1 (IFNAR1 to SOD1) known to contain the locus that causes horns, along 
with other genes with known roles in the osteogenesis and chrondrogenesis pathways. 
Our hypothesis was that the gene that determines the presence of horns is expressed in 
osteoprogenitor cells of the early fetus and will affect the expression of RUNX2, MSX1, 
MSX2, and/or TWIST1.  Therefore gene expression was evaluated by both qualitative 
and quantitative RT-PCR and by in situ hybridization. 
With the exception of OLIG1, which was only expressed in the brain, all of the 
genes investigated were expressed in fetal frontal and parietal bones by qualitative RT-
PCR.  When evaluated by realtime RT-PCR the level of expression of C21orf59, 
C21orf66, IL10RB, and SFRS15 was observed to increase in the frontal bone of horned 
samples from d 55 to d 70 of gestation. 
At d 60 of gestation a change in the shape of the frontal bone was observed, 
which has been reported to be the developmental stage when the horn bud appears.  At 
this time point, genes with known roles in osteogenesis and chondrogenesis (MSX1, 
TWIST1, RUNX2 and SOX9) were detected in frontal bone in cells from the osteoblast 
lineage as expected.  Furthermore, C21orf59, C21orf62, C21or66 and SFRS15 from the 
polled interval were localized to developing mesenchyme, osteoblasts and/or osteoclasts 
of the frontal bone, suggesting that each of these genes has a role in intramembranous 
bone formation.  In addition, gradients of expressed C21orf66 and SFRS15 were 
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detected in developing endochondral bone.  Unexpectedly, there was evidence of an 
antisense transcript of C21orf66 expressed in the same cell types as the sense transcript.  
Further characterization of this antisense transcript demonstrated that it covered the 
entire sense transcript. 
A model of the possible roles of C21orf59, C21orf62, C21orf66 and its antisense 
transcript, and SFRS15 in intramembranous bone formation is presented in Figure 4.14. 
Both fibroblast growth factor (FGF) and BMP are important precursors for osteoblast 
differentiation.  Distal-less homeobox 5 (DLX5) and RUNX2 are major regulators of 
bone differentiation.  It is known that BMP2 regulates DLX5, which is required for 
expression of RUNX2, and FGF and BMP are important for the expression of MSX1, 
MSX2, and TWIST1 in normal differentiation.  Mutations in the FGF and BMP 
pathways or in associated transcription factors result in skull malformations.  Based on 
observed expression in the mesenchyme, rather than just in mature osteoblasts or 
osteoclasts, C21orf66 and/or its antisense transcript become the most likely candidates 
for the polled locus.  However, a mutation that disrupts expression of any of these genes 
would be expected to detrimentally affect intramembranous bone formation and could 
therefore prevent the development of horns. 
A limitation of the current study was that fetal samples were collected from 
commercial cows without knowledge of their expected genotype at the polled locus.  
Future research that builds upon the data collected herein will require producing fetuses 
bred to be horned, polled or scurred.  It is expected that expression patterns of genes 
(OLIG2, C21orf49, TCP10L, C21orf77, and SOD1) from the polled interval that were 
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not investigated herein will be characterized in future studies.  In addition, quantitative 
RT-PCR and/or in situ hybridization must be completed for C21orf63, HUNK, IFNAR1, 
IFNAR2, MRAP, C21orf45, and IL10RB.  In vitro expression assays that enable relative 
levels of expression of genes from the polled interval to be perturbated will help 
elucidate the role of these genes in intramembranous or endochondral bone formation 
and the development of horns in cattle. 
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A. 
 
 
B. 
  
Figure 4.14. Model of the role of genes from the polled interval in intramembranous 
bone formation. A. Observed expression of genes classified by cell type. B. Schematic 
model showing how genes from the polled interval (C21orf66, C21orf59, SFRS15, and 
C21orf62) may interact with other signaling factors during osteoblast differentiation. s = 
sense, as = antisense. 
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APPENDIX A 
 
 
Figure A.1.  Fetal dissection for RNA extraction.  A. First incision was made between the frontal bones from the nasal bone 
cutting posteriorly to the occipital condyle.  B. Second incision was made from the nasal bone continuing posteriorly above the 
eye and ear, meeting the first incision at the occipital condyle.  C. The top portion of the head was removed just above the ear.  
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Figure A.2.  Fetal dissection for histology.  A. First incision is made between the frontal and nasal bones splitting the head. B. 
Second incision is made at the occipital condyle to remove the head. C. For analysis of the top portion of the head, an incision 
was made just above the ear continuing to the front just above the eyes. 
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APPENDIX B 
 
Table B.1.  Nomenclature of genes located in the polled interval and genes involved in osteogenesis and chondrogenesis. 
 
Role Gene Name
1 
Symbol1
 HSA
1,2 
Polled Interval chromosome 21 open reading frame 45 C21orf45 21q22.11 
 chromosome 21 open reading frame 59 C21orf59 21q22.1 
 chromosome 21 open reading frame 62 C21orf62 21q22.1 
 chromosome 21 open reading frame 63 C21orf63 21q22.11 
 chromosome 21 open reading frame 66 C21orf66 21q22.11 
 interleukin 10 receptor, beta IL10RB 21q22.1-q22.2 
 splicing factor, arginine/serine-rich 15 SFRS15 21q22.1 
 synaptojanin 1 SYNJ1 21q22.2 
 hormonally up-regulated Neu-associated kinase HUNK 21q22.1 
 interferon (alpha, beta and omega) receptor 1 IFNAR1 21q22.1 
 interferon (alpha, beta and omega) receptor 2 IFNAR2 21q22.1 
 melanocortin 2 receptor accessory protein MRAP 21q22.1 
 oligodendrocyte transcription factor 1 OLIG1 21q22.11 
Osteogenesis/ 
Chondrogenesis  bone morphogenetic protein 4 BMP4 14q22-q23 
 bone morphogenetic protein 7 BMP7 20q13 
 fibroblast growth factor receptor 2 FGFR2 10q25.3-q26 
 c-fos induced growth factor (vascular endothelial growth factor D) FIGF Xp22.31 
 msh homeobox 1 MSX1 4p16.2 
 msh homeobox 2 MSX2 5q35.2 
 runt-related transcription factor 1 RUNX1 21q22.3 
 runt-related transcription factor 2 RUNX2 6p21 
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Table B.1 continued. 
Role Gene Name
1 
Symbol1
 HSA
1,2 
Osteogenesis/ 
Chondrogenesis  protein kinase, cAMP-dependent, catalytic, alpha PRKACA 19p13.1 
 SRY (sex determining region Y)-box 9 SOX9 17q23 
 twist homolog 1 (Drosophila) TWIST1 7p21 
 twist homolog 2 (Drosophila) TWIST2 2q37.3 
 signal transducer and activator of transcription 1, 91kDa STAT1 2q32.2-q32.3 
 parathyroid hormone-like hormone PTHLH 12p12.1-p11.2 
 forkhead box FOXL2 3q23 
 gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis) GREM1 15q13.3 
 collagen, type XVIII, alpha 1 COL18A1 21q22.3 
 cysteine-rich, angiogenic inducer, 61 CYR61 1p22.3 
 glyceraldehyde-3-phosphate dehydrogenase GAPD 12p13.31  
 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, 
zeta polypeptide 
YWHAZ 
8q22.3 
1 From HUGO gene nomenclature. 
2 Human chromosome 
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